The individual contribution of genes in the HLA region to the risk of developing type 1 diabetes (T1D) is confounded by the high linkage disequilibrium (LD) in this region. Using a novel approach we have combined genetic association data with information on functional protein-protein interactions to elucidate risk independent of LD and to place the genetic association into a functional context.
Genetic association data from 2300 single nucleotide polymorphisms (SNPs) in the HLA region was analysed in 2200 T1D family trios divided into six risk groups based on HLA-DRB1 genotypes. The best SNP signal in each gene was mapped to proteins in a human protein interaction network and their significance of clustering in functional network modules was evaluated. The significant network modules identified through this approach differed between the six HLA risk groups, which could be divided into two groups based on carrying the DRB1*0301 or the DRB1*0401 allele. Proteins identified in networks specific for DRB1*0301 carriers were involved in stress response and inflammation whereas in DRB1*0401 carriers the proteins were involved in antigen processing and presentation.
In this study we were able to hypothesise functional differences between individuals with T1D carrying specific DRB1 alleles. The results point at candidate proteins involved in distinct cellular processes that could not only help the understanding of the pathogenesis of T1D, but also the distinction between individuals at different genetic risk for developing T1D.
Citation: Brorsson C, Tue Hansen N, Bergholdt R, Brunak S, Pociot F (2010) The Type 1 Diabetes - HLA Susceptibility Interactome - Identification of HLA Genotype-Specific Disease Genes for Type 1 Diabetes. PLoS ONE 5(3): e9576. https://doi.org/10.1371/journal.pone.0009576
Editor: Kathrin Maedler, University of Bremen, Germany
Received: May 27, 2009; Accepted: January 14, 2010; Published: March 5, 2010
Copyright: © 2010 Brorsson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. This study was funded by research grants from EFSD/JDRF/Novo Nordisk, the Danish Medical Research Council (271-05-0672), the Juvenile Diabetes Research Foundation (33-2008-391) and Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Type 1 diabetes (T1D) is a disease of complex aetiology believed to be influenced by multiple genetic and environmental risk factors. The major genetic signal for T1D is located in the human leukocyte antigen (HLA) region on the short arm of chromosome 6 (6p21.3). The contribution of this region to the risk of developing T1D has been known for over thirty years , however the causative variant or variants have yet not been fully identified. The major susceptibility for T1D has been mapped to the HLA class II genes HLA-DQB1, -DQA1 and -DRB1 , . Both susceptible and protective DR-DQ haplotypes exist in all populations . Associations from other genes in the region have also been reported –, however the extremely high linkage disequilibrium (LD) covering a large part of the HLA region makes it difficult to detect independent effects of individual genes  and these studies may have suffered from lack of statistical power to identify true effects due to small sample sizes and not dense enough genotyping. Recently novel statistical methods have been applied to genetic association data from the HLA region in T1D, and this has made it possible to identify effects of other genes independently of the effects at the classical HLA-DR, -DQ risk loci. These include HLA-B and HLA-A, located telomeric of the classical loci, and loci within the HLA class III region –. Still these new loci together with the HLA-DQB1, -DQA1 and -DRB1 loci cannot explain the full effect of this region. Additional loci with smaller or rarer effects are likely to exist. To detect such variants, we have focused on the development of an approach that investigates functional protein-protein interactions encoded by genes within the HLA region.
Functional relationships (e.g. co-expression, structural similarity, physical interactions) between proteins have been used to infer phenotypic effects of mutations in their corresponding genes. A thorough benchmark of the predictive power of different types of relationships showed that proteins involved in the same protein complexes had the highest tendency to also cause the same phenotype when mutated . Thus, proteins interacting physically tend to be involved in similar phenotypes, which has been shown in several species –. With several large-scale protein-protein interaction screens across different organisms being available, protein-protein interactions can now be applied systematically to discover new disease genes , .
In this study we have used an approach that combines genetic association data with information on protein-protein interactions to identify additional genes within the HLA region that contribute to the pathogenesis of T1D. Information on protein interactions for genes that contribute to susceptibility of complex diseases may give valuable clues of not only the functional implication of candidate genes but also about additional candidates. The genetic data was generated by the Type 1 Diabetes Genetics Consortium (T1DGC), in an effort to fine map the HLA region in a large cohort of T1D families collected world-wide, but mostly of Caucasian ethnicity. We have previously validated the method in a study of a subset of the T1DGC families in order to test whether information on functional interaction pathway could help explain the effects of the HLA region on the risk of developing T1D . Here we expand the study to contain over 2200 affected offspring trios and test whether different HLA-DRB1 genotypes carried by the diabetic offspring could confer different risk due to underlying differences at a functional level.
All study participants, their parents or guardians gave written consent to participate and the study protocol was approved by relevant Ethics Committees and Institutional Review Boards in each country contributing family material to the study (Danish: Den Videnskabsetiske Komité for Københavns Amt # KA 04090g).
The dataset generated by the T1DGC comprised 2321 T1D affected sib-pair families (release 2007.02.MHC). The samples comprised families from nine cohorts, Asia Pacific (AP), British Diabetes Association (BDA), Denmark (DEN), Europe (EUR), Human Biological Data Interchange (HBDI), Joslin (JOS), North America (NA), Sardinia (SAR) and United Kingdom (UK). All diabetic individuals were diagnosed before 35 years of age with continued insulin treatment since diagnosis.
Genotyping was performed on two chip arrays (OPA1 and OPA2) of 1536 SNPs each from the Illumina Golden Gate technology (San Diego, CA, USA). 115 SNPs were in common on the two chips resulting in 2957 unique SNPs distributed throughout the 4 Mb classical HLA region. In addition to the SNP genotyping all individuals were also genotyped for alleles in classical HLA genes (HLA-A, HLA-B, HLA-Cw, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1 and HLA-DRB1) using PCR-based sequence-specific oligonucleotide probes and line strips from Roche Molecular Systems (Pleasanton, CA, USA). The genotyping was presented at a four-digit level except for the BDA cohort. For details on DNA samples, genotyping and QC provided by the T1DGC see .
We used the information on HLA-DRB1 genotypes to stratify the probands according to carriage of the *0301, *0401 or non-*0301/non-*0401 alleles (here called X). For the probands that did not have four-digit genotyping their two-digit genotype 03 or 04 was used for stratification. This divided the probands and their two parents into six different genotype groups: DR*0301/DR*0401 (DR3/DR4), DR*0401/DR*0401 (DR4/DR4), DR*0301/DR*0301 (DR3/DR3), DR*0401/DRX (DR4/DRX), DR*0301/DRX (DR3/DRX) and DRX/DRX ranked according to their conferred risk of T1D.
Individuals were removed for low genotyping success rate (<90%). SNPs were removed for low genotyping success rate (<95%), a minor allele frequency less than 1%, deviation from Hardy Weinberg equilibrium (p<0.001) in controls, and if Mendelian errors were detected. Individuals that were removed for low genotyping reduced the number of full affected offspring trios available for analysis to 2214. They were analysed for association for the remaining SNPs using the transmission disequilibrium test (TDT) . All genetic analyses were performed using the program PLINK . The six datasets were analysed separately for association by TDT using the quality criteria mentioned. This resulted in 589 trios being analysed for 2317 SNPs in the DR3/DR4 group (26.6%), 145 trios for 2295 SNPs in DR4/DR4 (6.5%), 202 trios for 2289 SNPs in DR3/DR3 (9.1%), 444 trios for 2369 SNPS in DR4/DRX (20.1%), 570 trios for 2358 SNPs in DR3/DRX (25.8%) and 264 trios for 2389 SNPs in the DRX/DRX group (11.9%). More than 97% of the probands in the highest risk group, DR3/DR4, carried the high risk DQB1*0302 allele associated with the DR4-DQ8 haplotype.
Protein-Protein Interaction Networks
Protein interaction experiments are plagued by high numbers of false positive interactions and often low coverage. In order to derive a high-quality human interactome (the Inweb), we 1) combined several large scale protein-protein interaction databases, 2) inferred protein-protein interactions from model organisms, and 3) defined a quality control score for each interaction. For the purpose, we integrated interactions in 23,296 peer-reviewed articles retrieved from large protein-protein interaction databases and using the InParanoid orthology database, we inferred human protein-protein interactions from experiments in model organisms . All interactions were scored and benchmarked against a gold standard to ensure that only high-confidence interactions were used in the analysis. The resulting interactome contained 313,524 unique scored protein-protein interactions covering 12,275 proteins.
Discovering Protein-Protein Interaction Networks Involved in Diabetes
- The resource. As the genetic analyses specifically focused on the HLA region, we derived a protein interaction network of all proteins translated from genes in this region and their respective interaction partners. Such a network is often referred to as a 2nd order protein-protein interaction networks and here we will refer to the resource as the HLA-relevant protein-protein interaction network.
- Generating protein-protein interaction modules. Each gene in the HLA-relevant protein-protein interaction network was used as bait protein in a virtual pull-down, i.e. a module consisted of a bait protein and its direct protein-protein interaction partners. This approach resulted in an inventory of modules that could be screened for association to T1D.
- Genetic association and proteins. The TDT p-value for the SNP with the highest association to T1D was assigned to each gene including 2000 bp up- and downstream the transcription start and stop site, respectively. Thus each protein was associated to the most significant SNP lying within the gene.
- Cleaning up modules. As the association data from the HLA region only covers ∼6% of the nodes in the HLA-relevant protein-protein interaction network, each module was reduced to only include genes with associated TDT p-values. Hereby, modules in the inventory only included gene products from the HLA region. Pull-downs with less than two associated genes were dropped.
- Clustering of genetic association. For each protein-protein interaction module, the TDT p-values associated with each of the proteins were combined using a simple average. The combined TDT p-value for that module was then compared to a distribution of TDT p-values generated from 10,000 randomly sampled modules of the same size, i.e. the final p-value of a module was calculated as by dividing the number of random modules with a better combined p-value with 10,000.
The steps 3) to 5) were repeated for each experiment for all six HLA genotype risk groups. The most significantly enriched modules were selected for thorough study. Figure 1 gives an overview of the developed approach.
A) Genes located in the HLA region were identified and B) mapped to nodes or proteins in a 2nd order network in the InWeb. C) HLA proteins and their interaction partners were used as bait to produce virtual pull-downs of network modules. D) Identified network modules were reduced to only contain proteins from the HLA region, as these could be associated to signals from the TDT analysis. E) SNPs from the TDT analysis were mapped to genes + 2000 bp up- and downstream the transcription start and stop site respectively. The best SNP signal for each gene was then mapped to the corresponding proteins in the network modules.
In order to test whether the genetic association clustered within the HLA risk groups, we clustered the genetic association across all HLA groups as a reference. A two-sample Kolmogorov-Smirnov test was used to compare the p-value distributions for each of the HLA risk groups with the reference distribution (Figure 2). Table 1 lists the most significant network modules in each HLA risk group with information on bait proteins, the number of interaction partners within and outside the HLA region and p-values before and after correction with the reference.
A) DR3/DR3: most extreme deviation higher D = 0.2083, p<0.001. B) DR3/DRX: most extreme deviation higher D = 0.3347, p<0.001. C) DR3/DR4: most extreme deviation lower D = 0.2890, p<0.001. D) DR4/DR4: most extreme deviation lower D = 0.4772, p<0.001. E) DR4/DRX: most extreme deviation lower D = 0.1586, p<0.001. F) DRX/DRX: most extreme deviation lower D = 0.3199, p<0.001. Dashed line: HLA risk group, solid line: reference group.
Construction of Consensus Networks
Many proteins identified in the networks were present in more than one network and the number of interaction partners for these proteins was often large. To reduce the redundancy and identify interaction partners of special interest we used the information from all significant network modules within risk groups to construct consensus networks. For each HLA risk group, the number of times a gene was present at baseline in significant modules was counted. Table 2 summarises the most frequent genes within each group. As the number of baseline significant networks varies between the HLA risk groups, all genes appearing more than half as many times in baseline significant modules as the most frequent gene were used to seed a consensus HLA risk group-specific network associated with T1D. The consensus networks were visualised using Cytoscape .
205 genes from the HLA region could be mapped to nodes (or proteins) in the Inweb protein interaction network. In total, 744 pull-downs were constructed containing genes within the HLA region. Network modules significantly enriched for proteins from the HLA region were identified for each of the six HLA risk groups separately after the randomisation. The highest number of significant modules (p<0.05) was found for the DR3/DR3 and the DR3/DRX group, with 44 and 26 modules respectively. Looking closer at these results we found that 16 of the modules were shared between the DR3/DR3 and DR3/DRX groups. Similarly, the groups DR3/DR4, DR4/DR4 and DR4/DRX also showed an overlap of significant network modules. These three groups however, contained substantially fewer significant modules compared to the groups that did not carry a DRB1*0401 allele (6, 2 and 2 modules respectively). One module was found significant in the low risk DRX/DRX group. Figure 2 plots the distribution of p-values for the network modules for each of the six HLA risk groups compared to all HLA groups combined as reference. For each of the six HLA risk groups, we found more enrichment amongst the most significant clusters than we did when combining the samples across all HLA groups. The Kolmogorov-Smirnov test showed that the DR3/DR3 and the DR3/DRX groups were significantly more clustered than the combined sample (p<0.001), while the other four HLA risk groups generally were less clustered than the reference, except for the most associated networks. Of 81 significant networks identified after the randomisations three remained significant after adjusting the p-values with the reference, giving an FDR of 0.96. After correction we assume an FDR of 0.05 for the remaining three networks (Table 1).
Proteins in Identified Network Modules
For the DR3/DR3 and DR3/DRX risk groups proteins from the HLA region that were identified in significant network modules were found to overlap substantially. One protein in particular, the heat shock 70 kDa protein A1 (HSPA1A), was found in all of the most significant modules for these two groups. The two proteins HLA-B-associated transcript 3 (BAT3) and c6orf48 were also found together in three of the networks. Similarly, the modules in common between the DR*0401 allele-carrying groups (DR3/DR4, DR4/DR4 and DR4/DRX) were found to contain proteins that occurred multiple times. These were represented by classical HLA class II proteins, such as HLA-DQB1, -DQA1, proteasome subunits 8 and 9 (PSMB8, PSMB9) and transporter 1, ATP-binding cassette sub-family B (MDR/TAP) (TAP1) and transporter 2, ATP-binding cassette sub-family B (MDR/TAP) (TAP2). The single significant network module in the heterogeneous DRX/DRX group contained the classical HLA proteins HLA-DRB1, -DRB5, -DMA and -DRA.
Consensus networks for the six different HLA groups were constructed from the most abundant proteins in the significant modules to create a second order network. Their interaction partners outside the HLA region where included at the highest stringency level to visualise informative interaction pathways in which the HLA proteins are involved. The proteins and their functional implications in relation to immunity and T1D pathogenesis are summarised in Table 3 for the DRB1*0301 associated consensus network and Table 4 for the DRB1*0401 associated consensus networks.
The DR3/DR3 and the DR3/DRX groups shared the same consensus network centred around six proteins from the HLA region. The HLA proteins were identified as HSPA1A, HSPA1L (old name HSP70-Hom), c6orf48, tubulin beta (TUBB), casein kinase 2 beta subunit (CSNK2B) and discoidin domain receptor tyrosine kinase 1 (DDR1). Figure 3A shows their interaction relationships within and outside the HLA region and Table 3 summarises their information.
A) displays the consensus network for the DR3/DR3 and the DR3/DRX risk groups. B) displays the consensus network for the DR3/DR4 and the DR4/DRX risk group. C) displays the consensus network for the DR4/DR4 risk group. Proteins encoded from genes in the HLA region are shown in red.
Two consensus networks were shared by the DR3/DR4 and the DR4/DRX group. The smallest network containing the protein hypocretin (HCRT) was also the consensus network for the DR4/DR4 group. Once again they contained the proteins HLA-DQB1, -DQA1, PSMB8, PSMB9, TAP1 and TAP2 and their interaction partners outside the HLA (Figure 3B and C and Table 4).
The complex nature of the human HLA region on chromosome 6, with the extraordinarily high LD between genes, has made it extremely difficult to elucidate the effect of individual genes for the risk of developing T1D. A recent fine mapping study of the HLA region in T1D has identified and replicated additional risk loci within the HLA class I region . Independent association signals were identified for HLA-A and HLA-B, where HLA-B*039 conferred the highest risk for susceptibility. The class II-independent association of HLA-A and HLA-B has been replicated by recent studies –. Furthermore, evidence for independent association has been reported for the HLA-DPB1 locus ,  and for loci in the HLA class III region . Other loci have failed to replicate, such as the ITPR3 gene . Most of these recent studies have used data generated by the T1DGC, and they use refined statistical methods to control for the complexity of the HLA region due to the extended LD and highly polymorphic loci. Still the divergence of some results indicates the difficulty of dissecting the independent genetic contribution of genes in this region to the risk of developing T1D. It is likely that more genes with individual but smaller or rarer effects on diabetes risk can be identified in this region. However to find these genes new approaches for analysing genetic association data are needed.
In the current study we have developed a method which combines genetic association data with information on functional protein-protein interaction networks for the corresponding genes. Using a stratification based on HLA-DRB1 risk alleles we have identified functional protein interaction pathways that are able to discriminate between carriers of the *0301 or the *0401 risk alleles. One advantage of this approach is that it might make it possible to circumvent the issue with LD between genes as most interactions between proteins are not likely to depend on LD. However, we need to acknowledge that the extended LD between genes on chromosome 6p21 and the function of the genes within the same protein complexes make it difficult to account for LD in our analysis. Furthermore, the association signals from SNPs within genes within the HLA region are most likely confounded by the strong LD with HLA-DRB1, DQA1 and DQB1 alleles. In the developed approach we have evaluated the enrichment of T1D associated HLA proteins within interaction networks. Firstly, in the randomisation we compared the average association signal for each network to the signal from randomly generated HLA proteins networks that originated from the same TDT p-value distribution. Secondly, we compared the p-value distribution within each HLA risk group to the clustered distribution in the Kolmogorov-Smirnov test. In Figure 2 we can see that the DR3/3 and DR3/X groups are significantly more clustered than the reference. However, also the most associated networks in each HLA risk group have lower observed p-values than expected and are thus more clustered than the reference, indicating that the networks add information to the genetic association for the HLA risk groups. The protein-protein interaction analyses performed in the current study is in silico, however the identified interactions are based on documented interaction data with references in the literature, weighted towards physical interactions and should be useful for guiding future biological experiments . The protein-protein interaction data used in this study contained only high-confidence functional interactions, however many of the HLA proteins identified are involved in a large number of interactions with proteins outside the HLA region, as can be seen in Table 1. In an effort to reduce the complexity of the interactions contained in the network modules we constructed consensus networks based on the most abundant HLA proteins for each risk group and only included partners outside the HLA with a stringent criteria (see Methods).
Using this novel approach we were able to highlight functional interaction pathways for proteins that are encoded by the HLA region on chromosome 6. The common pathways that were identified for the carriers of the DRB1*0301 allele (summarised in Table 3) pinpoint genes and proteins involved in stress response and inflammation, such as the heat shock protein family and pathways leading to NF-κB activated gene transcription. Several of the genes that were identified as interaction partners outside the HLA region, although having diverse functions such as kinases, transcription factors and membrane transporters, are associated with roles in inflammation and thus constitute candidates with a role in the pathogenesis of autoimmunity.
In contrast the pathways identified in carriers of the DR*0401 allele (Table 4) highlighted proteins involved in antigen processing and transport, such as PSMB8, PSMB9, TAP1 and TAP2 as well as proteins involved in MHC class I and class II presentation. The genes PSMB8 and PSMB9 are located next to TAP1 and TAP2 in the class II region and encodes the inducible catalytic components LMP7 and LMP2 of the immunoproteasome, a specialised proteasome complex expressed upon stimulation with inflammatory cytokines. The proteasome is an enzymatic complex involved in the catalytic degradation of proteins in eukaryotic cells, including processing of antigenic peptides presented on MHC class I molecules . Another important role for the proteasome is the activation of NF-κB, via processing of the NF-κB precursor and degradation of the inhibitory protein IκBα. Several studies investigating the function of the immunoproteasome in DR4-associated immune-mediated diseases have found altered functions not only in antigen processing but also in other aspects of the immune response –.
Suggested environmental triggers of T1D have included viral infections and exposure to exogenous proteins, such as bovine insulin from cow's milk. The antigen processing pathway highlighted in the DR4-linked networks could provide indirect evidence for the involvement of exogenous proteins in the pathogenesis of immune-mediated diseases, as viral antigens are known to be processed via the immunoproteasome and presented on MHC class I molecules. Evidence for altered immunoproteasome expression and function following viral and parasite infection has also been demonstrated –. Taken together, these aspects of the immunoproteasome functions suggest a prominent role in regulating the immune response and pathogenesis of HLA DR-associated immune-mediated diseases.
In a previous publication , we proved the feasibility of using an approach that combines genetic association data with protein interaction networks using a subset of the data provided by the T1DGC. Apart from the classical HLA loci there is limited overlap with the network modules identified in the present study, although CD4 was found in significant networks in both studies. The reason for this lack of overlap may be the increase in statistical power provided by the increase in trios analysed in the full dataset, as well as the stratification and focus of this study on HLA risk groups. In addition the present study focuses on the most significant network modules identified, however some of the proteins identified in  were found among less significant modules identified in the present study (data not shown).
Our study emphasises the importance of systems biology approaches to complement more classical statistical analyses of the genetics of T1D and other complex diseases. Genes and proteins do not exert their functions as independent entities but are part of functional protein complexes and signalling pathways. The method that we have developed gives us the opportunity to place the genetic association into a functional context, which might help us understand the underlying mechanisms and complex interplay between multiple factors contributing to disease pathogenesis. The method is not only applicable in T1D but could also be applied to association data from other common complex diseases.
This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium.
Conceived and designed the experiments: CB NTH FP. Performed the experiments: CB NTH. Analyzed the data: CB NTH RB FP. Contributed reagents/materials/analysis tools: CB NTH RB SB FP. Wrote the paper: CB NTH RB SB FP.
- 1. Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, et al. (1974) HL-A antigens and diabetes mellitus. Lancet 2: 864–866.
- 2. She JX (1996) Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 17: 323–329.
- 3. Pociot F, McDermott MF (2002) Genetics of type 1 diabetes mellitus. Genes Immun 3: 235–249.
- 4. Cucca F, Lampis R, Congia M, Angius E, Nutland S, et al. (2001) A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 10: 2025–2037.
- 5. Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, et al. (1999) The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 64: 793–800.
- 6. Valdes AM, Erlich HA, Noble JA (2005) Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 66: 301–313.
- 7. Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, et al. (2002) The HLA class I A locus affects susceptibility to type 1 diabetes. Hum Immunol 63: 657–664.
- 8. Johansson S, Lie BA, Todd JA, Pociot F, Nerup J, et al. (2003) Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun 4: 46–53.
- 9. Valdes AM, Wapelhorst B, Concannon P, Erlich HA, Thomson G, et al. (2005) Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians. Tissue Antigens 65: 115–119.
- 10. Roach JC, Deutsch K, Li S, Siegel AF, Bekris LM, et al. (2006) Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. Am J Hum Genet 79: 614–627.
- 11. Nejentsev S, Gombos Z, Laine AP, Veijola R, Knip M, et al. (2000) Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49: 2217–2221.
- 12. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, et al. (2007) Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450: 887–892.
- 13. Howson JM, Walker NM, Clayton D, Todd JA (2009) Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab 11: Suppl 131–45.
- 14. Eike MC, Olsson M, Undlien DE, Dahl-Jorgensen K, Joner G, et al. (2008) Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families. Genes Immun.
- 15. Eike MC, Becker T, Humphreys K, Olsson M, Lie BA (2009) Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun 10: 56–67.
- 16. Valdes AM, Thomson G (2009) Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1. Diabetes Obes Metab 11: Suppl 146–52.
- 17. Fraser HB, Plotkin JB (2007) Using protein complexes to predict phenotypic effects of gene mutation. Genome Biol 8: R252.
- 18. van Driel MA, Bruggeman J, Vriend G, Brunner HG, Leunissen JA (2006) A text-mining analysis of the human phenome. Eur J Hum Genet 14: 535–542.
- 19. Gavin AC, Aloy P, Grandi P, Krause R, Boesche M, et al. (2006) Proteome survey reveals modularity of the yeast cell machinery. Nature 440: 631–636.
- 20. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, et al. (2003) A protein interaction map of Drosophila melanogaster. Science 302: 1727–1736.
- 21. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, et al. (2004) A map of the interactome network of the metazoan C. elegans. Science 303: 540–543.
- 22. Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, et al. (2007) A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 25: 309–316.
- 23. Wu X, Jiang R, Zhang MQ, Li S (2008) Network-based global inference of human disease genes. Mol Syst Biol 4: 189.
- 24. Brorsson C, Hansen NT, Lage K, Bergholdt R, Brunak S, et al. (2009) Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data. Diabetes Obes Metab 11: Suppl 160–66.
- 25. Brown WM, Pierce J, Hilner JE, Perdue LH, Lohman K, et al. (2009) Overview of the MHC fine mapping data. Diabetes Obes Metab 11: Suppl 12–7.
- 26. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506–516.
- 27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559–575.
- 28. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, et al. (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2: 2366–2382.
- 29. Sia C, Weinem M (2005) Genetic susceptibility to type 1 diabetes in the intracellular pathway of antigen processing - a subject review and cross-study comparison. Rev Diabet Stud 2: 40–52.
- 30. Muchamuel T, Basler M, Aujay MA, Suzuki E, Kalim KW, et al. (2009) A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med 15: 781–787.
- 31. Kimura HJ, Chen CY, Tzou SC, Rocchi R, Landek-Salgado MA, et al. (2009) Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice. PLoS One 4: e7857.
- 32. Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, et al. (2006) Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. J Clin Invest 116: 3195–3203.
- 33. Inoue S, Nakase H, Matsuura M, Mikami S, Ueno S, et al. (2009) The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease. Clin Exp Immunol 156: 172–182.
- 34. Tu L, Moriya C, Imai T, Ishida H, Tetsutani K, et al. (2009) Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection. Eur J Immunol.
- 35. Eisemann J, Prechtel AT, Muhl-Zurbes P, Steinkasserer A, Kummer M (2009) Herpes simplex virus type I infection of mature dendritic cells leads to reduced LMP7-mRNA-expression levels. Immunobiology 214: 861–867.
- 36. Basler M, Youhnovski N, Van Den Broek M, Przybylski M, Groettrup M (2004) Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus. J Immunol 173: 3925–3934.
- 37. Caplen NJ, Patel A, Millward A, Campbell RD, Ratanachaiyavong S, et al. (1990) Complement C4 and heat shock protein 70 (HSP70) genotypes and type I diabetes mellitus. Immunogenetics 32: 427–430.
- 38. Pociot F, Ronningen KS, Nerup J (1993) Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70-2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol 38: 491–495.
- 39. Kawaguchi Y, Ikegami H, Fukuda M, Fujioka Y, Shima K, et al. (1993) Polymorphism of HSP70 gene is not associated with type 1 (insulin-dependent) diabetes mellitus in Japanese. Diabetes Res Clin Pract 21: 103–107.
- 40. Berka N, Bland GN, Erabhaoui el H, Dunston GM (2007) Heat-shock protein gene is not associated with type-1 diabetes in African Americans. J Natl Med Assoc 99: 715–717.
- 41. Helqvist S, Polla BS, Johannesen J, Nerup J (1991) Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1 beta. Diabetologia 34: 150–156.
- 42. Welsh N, Welsh M, Lindquist S, Eizirik DL, Bendtzen K, et al. (1991) Interleukin-1 beta increases the biosynthesis of the heat shock protein hsp70 and selectively decreases the biosynthesis of five proteins in rat pancreatic islets. Autoimmunity 9: 33–40.
- 43. Abulafia-Lapid R, Gillis D, Yosef O, Atlan H, Cohen IR (2003) T cells and autoantibodies to human HSP70 in type 1 diabetes in children. J Autoimmun 20: 313–321.
- 44. Kerr JR (2005) Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence. J Vet Med B Infect Dis Vet Public Health 52: 335–339.
- 45. Bergholdt R, Storling ZM, Lage K, Karlberg EO, Olason PI, et al. (2007) Integrative analysis for finding genes and networks involved in diabetes and other complex diseases. Genome Biol 8: R253.
- 46. Litchfield DW (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369: 1–15.
- 47. Singh NN, Ramji DP (2008) Protein kinase CK2, an important regulator of the inflammatory response? J Mol Med 86: 887–897.
- 48. Matsuyama W, Wang L, Farrar WL, Faure M, Yoshimura T (2004) Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J Immunol 172: 2332–2340.
- 49. Palazzo M, Gariboldi S, Zanobbio L, Selleri S, Dusio GF, et al. (2008) Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa. J Immunol 181: 3126–3136.
- 50. Gaudreault N, Scriven DR, Moore ED (2004) Characterisation of glucose transporters in the intact coronary artery endothelium in rats: GLUT-2 upregulated by long-term hyperglycaemia. Diabetologia 47: 2081–2092.
- 51. Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, et al. (2002) Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 32: 321–325.
- 52. Rebbeck TR, Rennert H, Walker AH, Panossian S, Tran T, et al. (2008) Joint effects of inflammation and androgen metabolism on prostate cancer severity. Int J Cancer 123: 1385–1389.
- 53. Wermeling F, Chen Y, Pikkarainen T, Scheynius A, Winqvist O, et al. (2007) Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus. J Exp Med 204: 2259–2265.
- 54. Spiridonov NA, Wong L, Zerfas PM, Starost MF, Pack SD, et al. (2005) Identification and characterization of SSTK, a serine/threonine protein kinase essential for male fertility. Mol Cell Biol 25: 4250–4261.
- 55. Mehta JL, Li DY (1998) Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 248: 511–514.
- 56. Delneste Y, Magistrelli G, Gauchat J, Haeuw J, Aubry J, et al. (2002) Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353–362.
- 57. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O (1998) Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 334 (Pt 1): 9–13.
- 58. Lindfors K, Viiri KM, Niittynen M, Heinonen TY, Maki M, et al. (2003) TGF-beta induces the expression of SAP30L, a novel nuclear protein. BMC Genomics 4: 53.
- 59. Viiri KM, Korkeamaki H, Kukkonen MK, Nieminen LK, Lindfors K, et al. (2006) SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus. Nucleic Acids Res 34: 3288–3298.
- 60. Nishida K, Komiyama T, Miyazawa S, Shen ZN, Furumatsu T, et al. (2004) Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression. Arthritis Rheum 50: 3365–3376.
- 61. Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS (2003) Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest 111: 539–552.
- 62. Larsen L, Tonnesen M, Ronn SG, Storling J, Jorgensen S, et al. (2007) Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells. Diabetologia 50: 779–789.
- 63. Bray P, Lichter P, Thiesen HJ, Ward DC, Dawid IB (1991) Characterization and mapping of human genes encoding zinc finger proteins. Proc Natl Acad Sci U S A 88: 9563–9567.
- 64. Fichard A, Kleman JP, Ruggiero F (1995) Another look at collagen V and XI molecules. Matrix Biol 14: 515–531.
- 65. Frank NY, Pendse SS, Lapchak PH, Margaryan A, Shlain D, et al. (2003) Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 278: 47156–47165.
- 66. Chen KG, Szakacs G, Annereau JP, Rouzaud F, Liang XJ, et al. (2005) Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res 18: 102–112.
- 67. Matsuki K, Grumet FC, Lin X, Gelb M, Guilleminault C, et al. (1992) DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 339: 1052.
- 68. Siebold C, Hansen BE, Wyer JR, Harlos K, Esnouf RE, et al. (2004) Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A 101: 1999–2004.
- 69. Svejgaard A (2008) The immunogenetics of multiple sclerosis. Immunogenetics 60: 275–286.